Inventor
CASE MARTIN A
US14 patents
⚠️ This page may combine multiple inventors who share the name “CASE MARTIN A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
13 patentsUS10428134B2Oct 1, 2019
Immunoglobulins and uses thereof
JANSSEN PHARMACEUTICA NV7 citations92
US10968264B2Apr 6, 2021
Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
JANSSEN PHARMACEUTICA NV2 citations84
US11767354B2Sep 26, 2023
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
JANSSEN PHARMACEUTICA NV3 citations83
US11591379B2Feb 28, 2023
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
JANSSEN PHARMACEUTICA NV3 citations83
US11401315B2Aug 2, 2022
Immunoglobulins and uses thereof
JANSSEN PHARMACEUTICA NV2 citations83
US10968265B2Apr 6, 2021
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
JANSSEN PHARMACEUTICA NV4 citations83
US10858413B2Dec 8, 2020
Immunoglobulins and uses thereof
JANSSEN PHARMACEUTICA NV3 citations83
US10787495B2Sep 29, 2020
Immunoglobulins and uses thereof
JANSSEN PHARMACEUTICA NV3 citations83
US10640544B2May 5, 2020
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
JANSSEN PHARMACEUTICA NV4 citations83
US10961293B2Mar 30, 2021
Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
JANSSEN PHARMACEUTICA NV2 citations73
US12134636B2Nov 5, 2024
Immunoglobulins and uses thereof
JANSSEN PHARMACEUTICA NV0 citations72
US11732019B2Aug 22, 2023
Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
JANSSEN PHARMACEUTICA NV0 citations62
US10875902B2Dec 29, 2020
Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof
JANSSEN PHARMACEUTICA NV0 citations49